Exact Mass: 389.0296340000001

Exact Mass Matches: 389.0296340000001

Found 98 metabolites which its exact mass value is equals to given mass value 389.0296340000001, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

Progoitrin

[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydropyran-2-yl] (3R)-3-hydroxy-N-sulfooxy-pent-4-enimidothioate

C11H19NO10S2 (389.0450354)


Progoitrin is found in brassicas. Progoitrin is present in red cabbage, Brussel sprouts, savoy cabbage, Brassica napus (rape seed) and other Brassica species Progoitrin is a biochemical that is found in some food, which is inactive but after ingestion is converted to goitrin. Goitrin decrease the thyroid hormone production. 2-Hydroxy-3-butenyl glucosinolate is a natural product found in Zilla spinosa, Brassica incana, and other organisms with data available. Present in red cabbage, Brussel sprouts, savoy cabbage, Brassica napus (rape seed) and other Brassica subspecies Progoitrin is the stereoisomer of xi-progoitrin that has R at the carbon bearing the allylic hydroxy group. It has a role as a plant metabolite. It is a conjugate acid of a progoitrin(1-). Progoitrin is a natural product found in Isatis tinctoria and Brassica oleracea with data available. Acquisition and generation of the data is financially supported in part by CREST/JST. Progoitrin is the dominant glucosinolate in incriminated crops. Antithyroid activity[1][2]. Progoitrin is the dominant glucosinolate in incriminated crops. Antithyroid activity[1][2].

   

Acetyl adenylate

[[(2R,3S,4R,5R)-5-(6-Aminopurin-9-yl)-3,4-dihydroxy-tetrahydrofuran-2-yl]methoxy-hydroxy-phosphoryl] acetate

C12H16N5O8P (389.0736466)


Acetyl adenylate is an intermediate in acetyl-CoA synthesis. It is converted from acetate via the enzyme acetyl-CoA synthetase. It is involved in the non-enzymatic acetylation of histones in chromatin (PMID:8619849). In microbes acetyl adenylate also plays a role in the direction of flagellar rotation (PMID:2901103) [HMDB] Acetyl adenylate is an intermediate in acetyl-CoA synthesis. It is converted from acetate via the enzyme acetyl-CoA synthetase. It is involved in the non-enzymatic acetylation of histones in chromatin (PMID:8619849). In microbes acetyl adenylate also plays a role in the direction of flagellar rotation (PMID:2901103).

   

N-Acetylneuraminate 9-phosphate

(4R,5S,6S)-6-[(1R,2R)-1,2-dihydroxy-3-(phosphonooxy)propyl]-5-acetamido-2,4-dihydroxyoxane-2-carboxylic acid

C11H20NO12P (389.0723090000001)


N-Acetylneuraminate 9-phosphate is an intermediate in Aminosugars metabolism. N-Acetylneuraminate 9-phosphate is the 4th to last step in the synthesis of colominate and is converted from N-Acetyl-D-mannosamine-6-phosphate via the enzyme N-Acylneuraminate-9-phosphate synthase (EC 2.5.1.57). It is then converted to N-Acetylneuraminate via the enzyme N-acylneuraminate-9-phosphatase(EC 3.1.3.29). [HMDB] N-Acetylneuraminate 9-phosphate is an intermediate in Aminosugars metabolism. N-Acetylneuraminate 9-phosphate is the 4th to last step in the synthesis of colominate and is converted from N-Acetyl-D-mannosamine-6-phosphate via the enzyme N-Acylneuraminate-9-phosphate synthase (EC 2.5.1.57). It is then converted to N-Acetylneuraminate via the enzyme N-acylneuraminate-9-phosphatase(EC 3.1.3.29).

   

Cyclothiazide

3-{bicyclo[2.2.1]hept-5-en-2-yl}-6-chloro-1,1-dioxo-3,4-dihydro-2H-1λ⁶,2,4-benzothiadiazine-7-sulfonamide

C14H16ClN3O4S2 (389.0270726)


As a diuretic, cyclothiazide inhibits active chloride reabsorption at the early distal tubule via the Na-Cl cotransporter, resulting in an increase in the excretion of sodium, chloride, and water. Thiazides like cyclothiazide also inhibit sodium ion transport across the renal tubular epithelium through binding to the thiazide sensitive sodium-chloride transporter. This results in an increase in potassium excretion via the sodium-potassium exchange mechanism. The antihypertensive mechanism of cyclothiazide is less well understood although it may be mediated through its action on carbonic anhydrases in the smooth muscle or through its action on the large-conductance calcium-activated potassium (KCa) channel, also found in the smooth muscle. Cyclothiazide is indicated as adjunctive therapy in edema associated with congestive heart failure, hepatic cirrhosis, and corticosteroid and estrogen therapy. It is also indicated in the management of hypertension either as the sole therapeutic agent or to enhance the effectiveness of other antihypertensive drugs in the more severe forms of hypertension. C - Cardiovascular system > C03 - Diuretics > C03A - Low-ceiling diuretics, thiazides > C03AA - Thiazides, plain C78275 - Agent Affecting Blood or Body Fluid > C448 - Diuretic > C49185 - Thiazide Diuretic D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents D002317 - Cardiovascular Agents > D045283 - Natriuretic Agents D045283 - Natriuretic Agents > D004232 - Diuretics Same as: D01256 Cyclothiazide, a positive allosteric modulator of AMPA receptors, is used frequently to block the desensitization of both native and heterologously expressed AMPA receptors. Cyclothiazide is known to produce a fast inhibition of AMPA receptor desensitization and a much slower potentiation of the AMPA current[1].

   
   

N-Acetylneuraminic acid 9-phosphate

(4S,5R,6R)-6-[(1R,2R)-1,2-dihydroxy-3-(phosphonooxy)propyl]-5-acetamido-2,4-dihydroxyoxane-2-carboxylic acid

C11H20NO12P (389.0723090000001)


N-Acetylneuraminic acid 9-phosphate is an intermediate in the synthesis of Acetylneuraminic acid, a process occurring in the cytosolic fraction by the human enzyme N-Acetylneuraminic acid 9-phosphate (Neu5Ac 9-P) synthase, that catalyzes the synthesis of N-Acetylneuraminic acid 9-phosphate, in a reaction by the mechanism of aldol condensation of phosphoenolpyruvate (PEP) with sugar substrates, ManNAc-6-P (N-acetylmannosamine 6-phosphate) or Man-6-P (mannose 6-phosphate). N-Acetylneuraminic acid 9-phosphate is converted to N-Acetylneuraminic acid by the enzyme N-acetylneuraminate-9-phosphate phosphatase. (PMID: 16503877, 6093772) [HMDB] N-Acetylneuraminic acid 9-phosphate is an intermediate in the synthesis of Acetylneuraminic acid, a process occurring in the cytosolic fraction by the human enzyme N-Acetylneuraminic acid 9-phosphate (Neu5Ac 9-P) synthase, that catalyzes the synthesis of N-Acetylneuraminic acid 9-phosphate, in a reaction by the mechanism of aldol condensation of phosphoenolpyruvate (PEP) with sugar substrates, ManNAc-6-P (N-acetylmannosamine 6-phosphate) or Man-6-P (mannose 6-phosphate). N-Acetylneuraminic acid 9-phosphate is converted to N-Acetylneuraminic acid by the enzyme N-acetylneuraminate-9-phosphate phosphatase. (PMID: 16503877, 6093772).

   

2,3,4,6-Tetra-O-acetyl-beta-D-glucopyranosyl isothiocyanate

[3,4,5-Tris(acetyloxy)-6-isothiocyanatooxan-2-yl]methyl acetic acid

C15H19NO9S (389.07804840000006)


   

3',6'-Dihydroxy-6-isothiocyanatospiro[isobenzofuran-1(3H),9'-[9H]xanthen]-3-one

3,6-Dihydroxy-6-isothiocyanatospiro[isobenzofuran-1(3H),9-[9H]xanthen]-3-one

C21H11NO5S (389.03579160000004)


   

Fluorescein-5-isothiocyanate

3,6-Dihydroxy-5-isothiocyanatospiro(isobenzofuran-1(3H),9-(9H)xanthen)-3-one

C21H11NO5S (389.03579160000004)


D019995 - Laboratory Chemicals > D007202 - Indicators and Reagents > D049408 - Luminescent Agents D004396 - Coloring Agents > D005456 - Fluorescent Dyes > D005452 - Fluoresceins

   

Fluoresceine isothiocyanate

3,6-dihydroxy-8-isothiocyanato-3H-spiro[2-benzofuran-1,9-xanthene]-3-one

C21H11NO5S (389.03579160000004)


   

monophospho-n-acetylneuraminic acid

5-acetamido-4-hydroxy-2-(phosphonooxy)-6-(1,2,3-trihydroxypropyl)oxane-2-carboxylic acid

C11H20NO12P (389.0723090000001)


   

epiprogoitrin

2(S)-2-Hydroxy-3-butenyl glucosinolate

C11H19NO10S2 (389.0450354)


   
   
   

Celastramycin A

(3-chloro-5-hexyl-2,6-dihydroxyphenyl)(4,5-dichloro-1H-pyrrol-3-yl)-methanone

C17H18Cl3NO3 (389.03522080000005)


   

epi-Progoitrin

(2S)-2-Hydroxybut-3-enylglucosinolate

C11H19NO10S2 (389.0450354)


The stereoisomer of xi-progoitrin that has S at the carbon bearing the allylic hydroxy group. Acquisition and generation of the data is financially supported in part by CREST/JST.

   

progoitrin

(2R)-2-Hydroxybut-3-enylglucosinolate

C11H19NO10S2 (389.0450354)


Progoitrin is the dominant glucosinolate in incriminated crops. Antithyroid activity[1][2]. Progoitrin is the dominant glucosinolate in incriminated crops. Antithyroid activity[1][2].

   

(2S)-2-Hydroxybut-3-enylglucosinolate

(2S)-2-Hydroxybut-3-enylglucosinolate

C11H19NO10S2 (389.0450354)


   

(2R)-2-Hydroxybut-3-enylglucosinolate

(2R)-2-Hydroxybut-3-enylglucosinolate

C11H19NO10S2 (389.0450354)


Progoitrin is the dominant glucosinolate in incriminated crops. Antithyroid activity[1][2]. Progoitrin is the dominant glucosinolate in incriminated crops. Antithyroid activity[1][2].

   

(2R)-2-Hydroxy-3-butenyl glucosinolate

(2R)-2-Hydroxy-3-butenyl glucosinolate

C11H19NO10S2 (389.0450354)


Progoitrin is the dominant glucosinolate in incriminated crops. Antithyroid activity[1][2]. Progoitrin is the dominant glucosinolate in incriminated crops. Antithyroid activity[1][2].

   

(S)-2-hydroxy-3-butenyl glucosinolate

(S)-2-hydroxy-3-butenyl glucosinolate

C11H19NO10S2 (389.0450354)


   

(2R)-2-Hydroxy-3-Butenylglucosinolate

(2R)-2-Hydroxy-3-Butenylglucosinolate

C11H19NO10S2 (389.0450354)


Progoitrin is the dominant glucosinolate in incriminated crops. Antithyroid activity[1][2]. Progoitrin is the dominant glucosinolate in incriminated crops. Antithyroid activity[1][2].

   

cyclothiazide

cyclothiazide

C14H16ClN3O4S2 (389.0270726)


C - Cardiovascular system > C03 - Diuretics > C03A - Low-ceiling diuretics, thiazides > C03AA - Thiazides, plain C78275 - Agent Affecting Blood or Body Fluid > C448 - Diuretic > C49185 - Thiazide Diuretic D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents D002317 - Cardiovascular Agents > D045283 - Natriuretic Agents D045283 - Natriuretic Agents > D004232 - Diuretics Same as: D01256 Cyclothiazide, a positive allosteric modulator of AMPA receptors, is used frequently to block the desensitization of both native and heterologously expressed AMPA receptors. Cyclothiazide is known to produce a fast inhibition of AMPA receptor desensitization and a much slower potentiation of the AMPA current[1].

   

(2S)-2-Hydroxy-3-butenyl-glucosinolate

(2S)-2-Hydroxy-3-butenyl-glucosinolate

C11H19NO10S2 (389.0450354)


Annotation level-1

   

3-(4-BROMO-BENZENESULFONYL)-PYRROLIDINE-1-CARBOXYLIC ACID TERT-BUTYL ESTER

3-(4-BROMO-BENZENESULFONYL)-PYRROLIDINE-1-CARBOXYLIC ACID TERT-BUTYL ESTER

C15H20BrNO4S (389.0296340000001)


   
   

METHYL-3-NITRO-4-(3,5-DICARBOXYMETHYL-PHENOXY)-BENZOATE

METHYL-3-NITRO-4-(3,5-DICARBOXYMETHYL-PHENOXY)-BENZOATE

C18H15NO9 (389.074678)


   

tert-butyl 4-(5-iodopyridin-2-yl)piperazine-1-carboxylate

tert-butyl 4-(5-iodopyridin-2-yl)piperazine-1-carboxylate

C14H20IN3O2 (389.060021)


   

2-((tert-Butyldimethylsilyloxy)methyl)-6-iodofuro[3,2-b]pyridine

2-((tert-Butyldimethylsilyloxy)methyl)-6-iodofuro[3,2-b]pyridine

C14H20INO2Si (389.030801)


   

Thiazolidine, 2-(2-chlorophenyl)-3-(1-naphthalenylsulfonyl)- (9CI)

Thiazolidine, 2-(2-chlorophenyl)-3-(1-naphthalenylsulfonyl)- (9CI)

C19H16ClNO2S2 (389.0310946)


   
   

(2,3,4,5,6-pentafluorophenyl) 6-(oxan-4-yloxy)pyridine-3-carboxylate

(2,3,4,5,6-pentafluorophenyl) 6-(oxan-4-yloxy)pyridine-3-carboxylate

C17H12F5NO4 (389.06864520000005)


   

3-(2-BROMO-BENZENESULFONYL)-PYRROLIDINE-1-CARBOXYLIC ACID TERT-BUTYL ESTER

3-(2-BROMO-BENZENESULFONYL)-PYRROLIDINE-1-CARBOXYLIC ACID TERT-BUTYL ESTER

C15H20BrNO4S (389.0296340000001)


   

3-(3-BROMO-BENZENESULFONYL)-PYRROLIDINE-1-CARBOXYLIC ACID TERT-BUTYL ESTER

3-(3-BROMO-BENZENESULFONYL)-PYRROLIDINE-1-CARBOXYLIC ACID TERT-BUTYL ESTER

C15H20BrNO4S (389.0296340000001)


   

Fluorescein 6-isothiocyanate

Fluorescein isothiocyanate (Spiro Form)

C21H11NO5S (389.03579160000004)


   
   

2-[bis(2-phosphonooxyethyl)amino]ethyl dihydrogen phosphate

2-[bis(2-phosphonooxyethyl)amino]ethyl dihydrogen phosphate

C6H18NO12P3 (389.0041858)


   

PIK-93

N-(5-(4-Chloro-3-(N-(2-hydroxyethyl)sulfamoyl)phenyl)-4-methylthiazol-2-yl)acetamide

C14H16ClN3O4S2 (389.0270726)


   

3-IODO-6-NITRO-INDAZOLE-1-CARBOXYLIC ACID TERT-BUTYL ESTER

3-IODO-6-NITRO-INDAZOLE-1-CARBOXYLIC ACID TERT-BUTYL ESTER

C12H12IN3O4 (388.98725420000005)


   

Thiazolidine, 2-(4-chlorophenyl)-3-(1-naphthalenylsulfonyl)- (9CI)

Thiazolidine, 2-(4-chlorophenyl)-3-(1-naphthalenylsulfonyl)- (9CI)

C19H16ClNO2S2 (389.0310946)


   

sodium 2-(2,3-dihydro-1,3-dioxo-1H-inden-2-yl)-8-methylquinoline-6-sulphonate

sodium 2-(2,3-dihydro-1,3-dioxo-1H-inden-2-yl)-8-methylquinoline-6-sulphonate

C19H12NNaO5S (389.03338620000005)


   
   

2-CHLORO-5-(6-METHOXY-7-(2-METHOXYETHOXY)QUINAZOLIN-4-YLAMINO)CYCLOHEXA-2,5-DIENE-1,4-DIONE

2-CHLORO-5-(6-METHOXY-7-(2-METHOXYETHOXY)QUINAZOLIN-4-YLAMINO)CYCLOHEXA-2,5-DIENE-1,4-DIONE

C18H16ClN3O5 (389.07784360000005)


   
   

TAGIT

(3,4,5-Triacetyloxy-6-isothiocyanatooxan-2-yl)methyl acetate

C15H19NO9S (389.07804840000006)


   

Tungsten(5+) chloride ethanolate (1:2:3)

Tungsten(5+) chloride ethanolate (1:2:3)

C6H15Cl2O3W (388.990773)


   

2-Methyl-2-propanyl 4-[(5-bromo-1,3-thiazol-2-yl)carbamoyl]-1-pip eridinecarboxylate

2-Methyl-2-propanyl 4-[(5-bromo-1,3-thiazol-2-yl)carbamoyl]-1-pip eridinecarboxylate

C14H20BrN3O3S (389.04086700000005)


   
   

Benzenebutanoic acid, 2-hydroxy-3,4-dimethoxy-6-methyl-5-(sulfooxy)-, dipotassium salt

Benzenebutanoic acid, 2-hydroxy-3,4-dimethoxy-6-methyl-5-(sulfooxy)-, dipotassium salt

C13H18KO9S (389.03085780000004)


   

Vanadium,oxobis(1-phenyl-1,3-butanedionato-kO1,kO3)-

Vanadium,oxobis(1-phenyl-1,3-butanedionato-kO1,kO3)-

C20H18O5V (389.0593808)


   

DIETHYL2-((2-IODOPHENYLAMINO)METHYLENE)MALONATE

DIETHYL2-((2-IODOPHENYLAMINO)METHYLENE)MALONATE

C14H16INO4 (389.0124046)


   

Cipargamin

Cipargamin

C19H14Cl2FN3O (389.0497906)


C254 - Anti-Infective Agent > C276 - Antiparasitic Agent > C277 - Antiprotozoal Agent

   

[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl] (1E)-3-hydroxy-N-sulfooxypent-4-enimidothioate

[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl] (1E)-3-hydroxy-N-sulfooxypent-4-enimidothioate

C11H19NO10S2 (389.0450354)


   

N-Hydroxy-4-(methyl{[5-(2-pyridinyl)-2-thienyl]sulfonyl}amino)benzamide

N-Hydroxy-4-(methyl{[5-(2-pyridinyl)-2-thienyl]sulfonyl}amino)benzamide

C17H15N3O4S2 (389.05039500000004)


   

Adenosine phosphonoacetic acid

Adenosine phosphonoacetic acid

C12H16N5O8P (389.0736466)


   

Guanosine-2,3-O-ethylidenephosphonate

Guanosine-2,3-O-ethylidenephosphonate

C12H16N5O8P (389.0736466)


   

N-[4-(2-Chlorophenyl)-1,3-Dioxo-1,2,3,6-Tetrahydropyrrolo[3,4-C]carbazol-9-Yl]formamide

N-[4-(2-Chlorophenyl)-1,3-Dioxo-1,2,3,6-Tetrahydropyrrolo[3,4-C]carbazol-9-Yl]formamide

C21H12ClN3O3 (389.0567152000001)


   

R-2-Hydroxy-3-butenyl glucosinolate

R-2-Hydroxy-3-butenyl glucosinolate

C11H19NO10S2 (389.0450354)


   
   

(2S,4S,5R,6R)-5-acetamido-6-[(1R,2R)-1,2-dihydroxy-3-phosphonooxypropyl]-2,4-dihydroxyoxane-2-carboxylic acid

(2S,4S,5R,6R)-5-acetamido-6-[(1R,2R)-1,2-dihydroxy-3-phosphonooxypropyl]-2,4-dihydroxyoxane-2-carboxylic acid

C11H20NO12P (389.0723090000001)


   

1-(4-Amino-1,2,5-oxadiazol-3-yl)-5-[(1,3-benzothiazol-2-ylthio)methyl]-4-triazolecarboxylic acid methyl ester

1-(4-Amino-1,2,5-oxadiazol-3-yl)-5-[(1,3-benzothiazol-2-ylthio)methyl]-4-triazolecarboxylic acid methyl ester

C14H11N7O3S2 (389.03647759999996)


   

1-(2-Chloro-10-phenothiazinyl)-2-[(1-methyl-5-tetrazolyl)thio]ethanone

1-(2-Chloro-10-phenothiazinyl)-2-[(1-methyl-5-tetrazolyl)thio]ethanone

C16H12ClN5OS2 (389.0171772)


   

8-Nitroguanosine 3,5-cyclic monophosphate(1-)

8-Nitroguanosine 3,5-cyclic monophosphate(1-)

C10H10N6O9P- (389.024688)


   

1-S-[(3S)-3-hydroxy-N-(sulfooxy)pent-4-enimidoyl]-1-thio-beta-D-glucopyranose

1-S-[(3S)-3-hydroxy-N-(sulfooxy)pent-4-enimidoyl]-1-thio-beta-D-glucopyranose

C11H19NO10S2 (389.0450354)


   

2-chloro-N-[3-[(6-methoxy-1,3-benzothiazol-2-yl)amino]-3-oxopropyl]benzamide

2-chloro-N-[3-[(6-methoxy-1,3-benzothiazol-2-yl)amino]-3-oxopropyl]benzamide

C18H16ClN3O3S (389.0600856000001)


   

2-[acetyl(2-furanylmethyl)amino]-N-(4-chlorophenyl)-5-methyl-4-thiazolecarboxamide

2-[acetyl(2-furanylmethyl)amino]-N-(4-chlorophenyl)-5-methyl-4-thiazolecarboxamide

C18H16ClN3O3S (389.0600856000001)


   

Acetic acid [4-[2-(4-sulfamoylanilino)-4-thiazolyl]phenyl] ester

Acetic acid [4-[2-(4-sulfamoylanilino)-4-thiazolyl]phenyl] ester

C17H15N3O4S2 (389.05039500000004)


   

2-Chloro-N-[(E)-(5-morpholin-4-ylthiophen-2-yl)methylideneamino]-5-(trifluoromethyl)aniline

2-Chloro-N-[(E)-(5-morpholin-4-ylthiophen-2-yl)methylideneamino]-5-(trifluoromethyl)aniline

C16H15ClF3N3OS (389.0576406)


   

1-S-[3-hydroxy-N-(sulfooxy)pent-4-enimidoyl]-1-thio-beta-D-glucopyranose

1-S-[3-hydroxy-N-(sulfooxy)pent-4-enimidoyl]-1-thio-beta-D-glucopyranose

C11H19NO10S2 (389.0450354)


   

[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl] (1Z,3R)-3-hydroxy-N-sulfooxypent-4-enimidothioate

[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl] (1Z,3R)-3-hydroxy-N-sulfooxypent-4-enimidothioate

C11H19NO10S2 (389.0450354)


   

2-[2-(1,3-Benzothiazol-2-ylsulfonyl)ethylthio]-4,6-dimethyl-3-pyridinecarbonitrile

2-[2-(1,3-Benzothiazol-2-ylsulfonyl)ethylthio]-4,6-dimethyl-3-pyridinecarbonitrile

C17H15N3O2S3 (389.032637)


   

2-[[(2,5-dichloro-3-thiophenyl)-oxomethyl]amino]-6-methyl-5,7-dihydro-4H-thieno[2,3-c]pyridine-3-carboxamide

2-[[(2,5-dichloro-3-thiophenyl)-oxomethyl]amino]-6-methyl-5,7-dihydro-4H-thieno[2,3-c]pyridine-3-carboxamide

C14H13Cl2N3O2S2 (388.9826218)


   

Ethyl 4-{[2-(2,3,4,5,6-pentafluorophenoxy)acetyl]amino}benzoate

Ethyl 4-{[2-(2,3,4,5,6-pentafluorophenoxy)acetyl]amino}benzoate

C17H12F5NO4 (389.06864520000005)


   
   

[(2R,3S,4R,5R,6S)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl] (1Z,3S)-3-hydroxy-N-sulfooxypent-4-enimidothioate

[(2R,3S,4R,5R,6S)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl] (1Z,3S)-3-hydroxy-N-sulfooxypent-4-enimidothioate

C11H19NO10S2 (389.0450354)


   

Progoitrin

[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydropyran-2-yl] (3R)-3-hydroxy-N-sulfooxy-pent-4-enimidothioate

C11H19NO10S2 (389.0450354)


Progoitrin is the stereoisomer of xi-progoitrin that has R at the carbon bearing the allylic hydroxy group. It has a role as a plant metabolite. It is a conjugate acid of a progoitrin(1-). Progoitrin is a natural product found in Isatis tinctoria and Brassica oleracea with data available. The stereoisomer of xi-progoitrin that has R at the carbon bearing the allylic hydroxy group. Progoitrin is the dominant glucosinolate in incriminated crops. Antithyroid activity[1][2]. Progoitrin is the dominant glucosinolate in incriminated crops. Antithyroid activity[1][2].

   

N-Acetylneuraminic acid 9-phosphate

N-Acetylneuraminic acid 9-phosphate

C11H20NO12P (389.0723090000001)


   
   

6-FITC

Fluorescein-5-isothiocyanate

C21H11NO5S (389.03579160000004)


D019995 - Laboratory Chemicals > D007202 - Indicators and Reagents > D049408 - Luminescent Agents D004396 - Coloring Agents > D005456 - Fluorescent Dyes > D005452 - Fluoresceins

   

xi-Progoitrin

xi-Progoitrin

C11H19NO10S2 (389.0450354)


A hydroxy-alkenylglucosinolic acid in which a 3-hydroxybut-1-en-4-yl group is attached to the carbon of the oxime sulfate moiety.

   

5-Acetylphosphoadenosine

5-Acetylphosphoadenosine

C12H16N5O8P (389.0736466)


   

A-61603

A-61603

C14H20BrN3O3S (389.04086700000005)


A-61603 is a selective α1A-adrenergic receptor agonist[1]. A-61603 increases the frequency of spontaneous Ca2+ transients in rat ventricular myocytes in vitro[2].

   

ASM-IN-1

ASM-IN-1

C16H12BrN3O4 (389.0011132)


ASM-IN-1 is a potent and orally active acid sphingomyelinase (ASM) inhibitor with an IC50 value of 1.5 μM. ASM-IN-1 reduces lipid plaques in the aortic arch and aorta and reduces plasma ceramide concentration and Ox-LDL levels. ASM-IN-1 shows antiatherosclerotic and anti-inflammatory activity[1].

   

methyl (2s)-3-[(1z,12z)-13-bromo-13-chlorotrideca-1,12-dien-1-yl]-2h-azirine-2-carboxylate

methyl (2s)-3-[(1z,12z)-13-bromo-13-chlorotrideca-1,12-dien-1-yl]-2h-azirine-2-carboxylate

C17H25BrClNO2 (389.075708)


   

[(z)-[(3r)-3-hydroxy-1-{[(2r,3s,4r,5r,6s)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]sulfanyl}pent-4-en-1-ylidene]amino]oxysulfonic acid

[(z)-[(3r)-3-hydroxy-1-{[(2r,3s,4r,5r,6s)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]sulfanyl}pent-4-en-1-ylidene]amino]oxysulfonic acid

C11H19NO10S2 (389.0450354)


   

n-[2-(3-bromo-4-hydroxyphenyl)ethenyl]-3-(4-hydroxyphenyl)-2-methoxyprop-2-enamide

n-[2-(3-bromo-4-hydroxyphenyl)ethenyl]-3-(4-hydroxyphenyl)-2-methoxyprop-2-enamide

C18H16BrNO4 (389.02626360000005)


   

methyl 3-(13-bromo-13-chlorotrideca-1,12-dien-1-yl)-2h-azirine-2-carboxylate

methyl 3-(13-bromo-13-chlorotrideca-1,12-dien-1-yl)-2h-azirine-2-carboxylate

C17H25BrClNO2 (389.075708)


   

[(e)-[(3s)-3-hydroxy-1-{[(2r,3r,4s,5r,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]sulfanyl}pent-4-en-1-ylidene]amino]oxysulfonic acid

[(e)-[(3s)-3-hydroxy-1-{[(2r,3r,4s,5r,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]sulfanyl}pent-4-en-1-ylidene]amino]oxysulfonic acid

C11H19NO10S2 (389.0450354)


   

[(3-hydroxy-1-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]sulfanyl}pent-4-en-1-ylidene)amino]oxysulfonic acid

[(3-hydroxy-1-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]sulfanyl}pent-4-en-1-ylidene)amino]oxysulfonic acid

C11H19NO10S2 (389.0450354)


   

(e,2z)-n-[(1e)-2-(3-bromo-4-hydroxyphenyl)ethenyl]-3-(4-hydroxyphenyl)-2-methoxyprop-2-enimidic acid

(e,2z)-n-[(1e)-2-(3-bromo-4-hydroxyphenyl)ethenyl]-3-(4-hydroxyphenyl)-2-methoxyprop-2-enimidic acid

C18H16BrNO4 (389.02626360000005)


   

(4s,5r,6r)-6-[(1r,2r)-1,2-dihydroxy-3-(phosphonooxy)propyl]-2,4-dihydroxy-5-[(1-hydroxyethylidene)amino]oxane-2-carboxylic acid

(4s,5r,6r)-6-[(1r,2r)-1,2-dihydroxy-3-(phosphonooxy)propyl]-2,4-dihydroxy-5-[(1-hydroxyethylidene)amino]oxane-2-carboxylic acid

C11H20NO12P (389.0723090000001)


   

[(3-hydroxy-1-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]sulfanyl}pent-4-en-1-ylidene)amino]oxysulfonic acid

[(3-hydroxy-1-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]sulfanyl}pent-4-en-1-ylidene)amino]oxysulfonic acid

C11H19NO10S2 (389.0450354)


   

4-chloro-2-(4,5-dichloro-1h-pyrrole-3-carbonyl)-6-hexylbenzene-1,3-diol

4-chloro-2-(4,5-dichloro-1h-pyrrole-3-carbonyl)-6-hexylbenzene-1,3-diol

C17H18Cl3NO3 (389.03522080000005)


   

[(z)-[(3r)-3-hydroxy-1-{[(2r,3r,4s,5r,6s)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]sulfanyl}pent-4-en-1-ylidene]amino]oxysulfonic acid

[(z)-[(3r)-3-hydroxy-1-{[(2r,3r,4s,5r,6s)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]sulfanyl}pent-4-en-1-ylidene]amino]oxysulfonic acid

C11H19NO10S2 (389.0450354)


   

[(e)-[(3r)-3-hydroxy-1-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]sulfanyl}pent-4-en-1-ylidene]amino]oxysulfonic acid

[(e)-[(3r)-3-hydroxy-1-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]sulfanyl}pent-4-en-1-ylidene]amino]oxysulfonic acid

C11H19NO10S2 (389.0450354)